FT
How vaccine laggard CureVac hopes to come out on top
A transatlantic tug of love and a CEO brain haemorrhage afflicted the Bill Gates-backed biotech
A transatlantic tug of love and a CEO brain haemorrhage afflicted the Bill Gates-backed biotech